Monoclonal antibodies (mAbs) have become the most growth-accelerated segment of the biopharmaceutical industry, with advanced molecular engineering and antibody humanization making it possible to ...
MINNEAPOLIS, July 28, 2021 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) and PROGEN today announced the launch of the Simple Plex™ Adeno-Associated Virus (AAV2) viral titer assay for AAV2 ...
In a recent study posted to the medRxiv* server, researchers evaluated whether serologic testing could help estimate the risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection ...
The advent of gene therapy has unlocked new possibilities for treating diseases previously regarded as intractable. However, producing adeno-associated virus (AAV)-mediated gene therapy products ...
Simple Plex AAV assays combine industry leading AAV antibody reagents from PROGEN with convenience and simplicity of the fully automated Ella platform. MINNEAPOLIS, Oct. 11, 2022 /PRNewswire/ -- ...
Gene therapy (introducing genetic material into living cells to fix, replace, enhance, or block a faulty gene) is rapidly gaining traction as a strategy for the treatment of genetic diseases. The ...
Gene therapy is a rapidly growing area for therapeutic development, due to the potential to cure a wide range of genetic disorders. Although gene therapy has been around for many years, advances in ...
The use of biologic-based therapeutics has revolutionized our ability to treat complex diseases such as cancer- and autoimmune-related disorders. Biologic-based therapeutics are known to generate anti ...
Background. The phase III Zostavax Efficacy and Safety Trial of 1 dose of licensed zoster vaccine (ZV; Zostavax; Merck) in 50-59-year-olds showed approximately 70% vaccine efficacy (VE) to reduce the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback